Literature DB >> 17611545

The disappearing Barr body in breast and ovarian cancers.

Gayle J Pageau1, Lisa L Hall, Shridar Ganesan, David M Livingston, Jeanne B Lawrence.   

Abstract

Interest has recently reawakened in whether loss of the heterochromatic X chromosome (Barr body) is prevalent in certain breast and ovarian cancers, and new insights into the mechanisms involved have emerged. Mitotic segregation errors commonly explain the loss of the inactive X chromosome (Xi), but compromise of Xi heterochromatin in some cancers may signal broader deficits of nuclear heterochromatin. The debated link between BRCA1 and Xi might reflect a general relationship between BRCA1 and heterochromatin, which could connect BRCA1 to both epigenetic and genetic instability. We suggest that heterochromatic instability is a common but largely unexplored mechanism, leading to widespread genomic misregulation and the evolution of some cancers.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17611545     DOI: 10.1038/nrc2172

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  54 in total

Review 1.  Heterochromatin instability in cancer: from the Barr body to satellites and the nuclear periphery.

Authors:  Dawn M Carone; Jeanne B Lawrence
Journal:  Semin Cancer Biol       Date:  2012-06-18       Impact factor: 15.707

2.  Molecular signatures of human induced pluripotent stem cells highlight sex differences and cancer genes.

Authors:  Montserrat C Anguera; Ruslan Sadreyev; Zhaoqing Zhang; Attila Szanto; Bernhard Payer; Steven D Sheridan; Showming Kwok; Stephen J Haggarty; Mriganka Sur; Jason Alvarez; Alexander Gimelbrant; Maisam Mitalipova; James E Kirby; Jeannie T Lee
Journal:  Cell Stem Cell       Date:  2012-07-06       Impact factor: 24.633

Review 3.  Long Noncoding RNAs: At the Intersection of Cancer and Chromatin Biology.

Authors:  Adam M Schmitt; Howard Y Chang
Journal:  Cold Spring Harb Perspect Med       Date:  2017-07-05       Impact factor: 6.915

4.  Molecular signatures of X chromosome inactivation and associations with clinical outcomes in epithelial ovarian cancer.

Authors:  Stacey J Winham; Nicholas B Larson; Sebastian M Armasu; Zachary C Fogarty; Melissa C Larson; Brian M McCauley; Chen Wang; Kate Lawrenson; Simon Gayther; Julie M Cunningham; Brooke L Fridley; Ellen L Goode
Journal:  Hum Mol Genet       Date:  2019-04-15       Impact factor: 6.150

Review 5.  Unfolding the story of chromatin organization in senescent cells.

Authors:  Eric C Swanson; Lindsy M Rapkin; David P Bazett-Jones; Jeanne B Lawrence
Journal:  Nucleus       Date:  2015-06-24       Impact factor: 4.197

6.  An integrative approach to assess X-chromosome inactivation using allele-specific expression with applications to epithelial ovarian cancer.

Authors:  Nicholas B Larson; Zachary C Fogarty; Melissa C Larson; Kimberly R Kalli; Kate Lawrenson; Simon Gayther; Brooke L Fridley; Ellen L Goode; Stacey J Winham
Journal:  Genet Epidemiol       Date:  2017-11-08       Impact factor: 2.135

Review 7.  Long noncoding RNAs: fresh perspectives into the RNA world.

Authors:  Lin Yang; John E Froberg; Jeannie T Lee
Journal:  Trends Biochem Sci       Date:  2013-11-27       Impact factor: 13.807

Review 8.  Deciphering the Role of the Barr Body in Malignancy: An insight into head and neck cancer.

Authors:  Deepti Sharma; George Koshy; Shruti Gupta; Bhushan Sharma; Sonal Grover
Journal:  Sultan Qaboos Univ Med J       Date:  2018-01-10

9.  Comparison of rat fetal sex determination using placental gDNA and mRNA via qRT-PCR.

Authors:  Anthony L Su; Rita Loch-Caruso
Journal:  J Mol Biol Methods       Date:  2020-07-05

10.  Misbehaviour of XIST RNA in breast cancer cells.

Authors:  Silvia M Sirchia; Silvia Tabano; Laura Monti; Maria P Recalcati; Manuela Gariboldi; Francesca R Grati; Giovanni Porta; Palma Finelli; Paolo Radice; Monica Miozzo
Journal:  PLoS One       Date:  2009-05-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.